PharmaEdge is an integrated solution for the pharmaceutical industry – all the benefits of SCADA and a powerful control system in one device.
B&R has developed an integrated single-PC solution for users in the pharmaceutical industry to monitor and control their entire operations, which also meets the increasing FDA compliance demands. PharmaEdge offers all the benefits of SCADA and a powerful control system in one device. With possibilities to add energy monitoring, condition-based predictive maintenance, and MES/ERP connectivity, it enables the implementation of smart machines for the future of the industry.
Integrated PharmaEdge architecture
The integrated PharmaEdge solution helps users optimize their automation systems’ performance while simultaneously improving cost and energy efficiency. Instead of deploying separate control systems for process control, SCADA, energy monitoring, and condition monitoring, users get all this functionality in a single, integrated system with built-in cybersecurity. With this one-box solution, users will be able to monitor as well as control their entire operations.
PharmaEdge consists of a B&R industrial PC running a hypervisor solution with Linux and Automation Runtime operating systems. It offers machine and process automation libraries for easy configuration. There are no limitations to internal tags and no incremental costs for additional tags. Built-in features support easy reporting and historical data retrieval.
Compliance with FDA 21 CFR Part 11
Quality, regulatory compliance, safety, easy track-and-trace, and efficient data access are the trademarks of a world-class pharmaceutical facility. PharmaEdge provides a quick and easy way to implement and customize audit trails. System manufacturers and end-users benefit from maximum security without having to implement organizational measures. Features offered by PharmaEdge include data archiving and retrieval, electronic signatures, batch reporting, access protection, and central user management, as well as audit trail and change management.
The impact, resilience, and growth of responsible packaging in a wide region are daily chronicled by Packaging South Asia.
A multi-channel B2B publication and digital platform such as Packaging South Asia is always aware of the prospect of new beginnings and renewal. Its 16-year-old print monthly, based in New Delhi, India has
demonstrated its commitment to progress and growth. The Indian and Asian packaging industries have shown resilience in the face of ongoing challenges over the past three years.
As we present our publishing plan for 2023, India’s real GDP growth for the financial year ending 31 March 2023 will reach 6.3%. Packaging industry growth has exceeded GDP growth even when allowing for inflation in the past three years.
The capacity for flexible film manufacturing in India increased by 33% over the past three years. With orders in place, we expect another 33% capacity addition from 2023 to 2025. Capacities in monocartons, corrugation, aseptic liquid packaging, and labels have grown similarly. The numbers are positive for most of the economies in the region – our platform increasingly reaches and influences these.
Even given the disruptions of supply chains, raw material prices, and the challenge of responsible and sustainable packaging, packaging in all its creative forms and purposes has significant headroom to grow in India and Asia. Our context and coverage engulf the entire packaging supply chain – from concept to shelf and further – to waste collection and recycling. We target brand owners, product managers, raw material suppliers, packaging designers and converters, and recyclers.
In an admittedly fragmented and textured terrain, this is the right time to plan your participation and marketing support communication – in our impactful and highly targeted business platform. Tell us what
you need. Speak and write to our editorial and advertising teams!
For advertisement ads1@ippgroup.in , for editorial info@ippgroup.in and for subscriptions subscription@ippgroup.in
